KONINKLIJKE PHILIPS NV (PHIA.AS) Stock Fundamental Analysis
Europe - Euronext Amsterdam - AMS:PHIA - NL0000009538 - Common Stock
22.685 EUR
-0.16 (-0.68%)
Overall PHIA gets a fundamental rating of 3 out of 10. We evaluated PHIA against 65 industry peers in the Health Care Equipment & Supplies industry. PHIA may be in some trouble as it scores bad on both profitability and health. PHIA has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year PHIA was profitable.
PHIA had a positive operating cash flow in the past year.
In multiple years PHIA reported negative net income over the last 5 years.
PHIA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
With a Return On Assets value of 0.61%, PHIA is not doing good in the industry: 64.62% of the companies in the same industry are doing better.
With a Return On Equity value of 1.56%, PHIA is not doing good in the industry: 64.62% of the companies in the same industry are doing better.
The Return On Invested Capital of PHIA (4.27%) is worse than 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROIC | 4.27% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PHIA has a Profit Margin of 0.91%. This is in the lower half of the industry: PHIA underperforms 64.62% of its industry peers.
PHIA's Operating Margin of 6.11% is in line compared to the rest of the industry. PHIA outperforms 41.54% of its industry peers.
PHIA's Operating Margin has declined in the last couple of years.
PHIA has a worse Gross Margin (43.85%) than 75.38% of its industry peers.
PHIA's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% |
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
PHIA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, PHIA has less shares outstanding
The number of shares outstanding for PHIA has been increased compared to 5 years ago.
The debt/assets ratio for PHIA is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 1.88 indicates that PHIA is not a great score, but indicates only limited risk for bankruptcy at the moment.
PHIA's Altman-Z score of 1.88 is on the low side compared to the rest of the industry. PHIA is outperformed by 60.00% of its industry peers.
PHIA has a debt to FCF ratio of 19.41. This is a negative value and a sign of low solvency as PHIA would need 19.41 years to pay back of all of its debts.
PHIA's Debt to FCF ratio of 19.41 is in line compared to the rest of the industry. PHIA outperforms 41.54% of its industry peers.
PHIA has a Debt/Equity ratio of 0.69. This is a neutral value indicating PHIA is somewhat dependend on debt financing.
The Debt to Equity ratio of PHIA (0.69) is worse than 73.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Altman-Z | 1.88 |
ROIC/WACC0.66
WACC6.47%
2.3 Liquidity
A Current Ratio of 1.26 indicates that PHIA should not have too much problems paying its short term obligations.
PHIA has a Current ratio of 1.26. This is in the lower half of the industry: PHIA underperforms 64.62% of its industry peers.
PHIA has a Quick Ratio of 1.26. This is a bad value and indicates that PHIA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.81, PHIA is not doing good in the industry: 69.23% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 |
3. Growth
3.1 Past
PHIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.15%, which is quite good.
PHIA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.17% yearly.
Looking at the last year, PHIA shows a decrease in Revenue. The Revenue has decreased by -0.81% in the last year.
The Revenue has been growing slightly by 1.00% on average over the past years.
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%
3.2 Future
The Earnings Per Share is expected to grow by 13.05% on average over the next years. This is quite good.
PHIA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.41% yearly.
EPS Next Y4.35%
EPS Next 2Y4.98%
EPS Next 3Y7.73%
EPS Next 5Y13.05%
Revenue Next Year-2.27%
Revenue Next 2Y0.25%
Revenue Next 3Y1.58%
Revenue Next 5Y3.41%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 15.33 indicates a correct valuation of PHIA.
Compared to the rest of the industry, the Price/Earnings ratio of PHIA indicates a rather cheap valuation: PHIA is cheaper than 92.31% of the companies listed in the same industry.
PHIA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.39.
A Price/Forward Earnings ratio of 14.86 indicates a correct valuation of PHIA.
Based on the Price/Forward Earnings ratio, PHIA is valued a bit cheaper than the industry average as 70.77% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.84. PHIA is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.33 | ||
| Fwd PE | 14.86 |
4.2 Price Multiples
PHIA's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. PHIA is cheaper than 73.85% of the companies in the same industry.
PHIA's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 50.33 | ||
| EV/EBITDA | 11.98 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)3.53
PEG (5Y)N/A
EPS Next 2Y4.98%
EPS Next 3Y7.73%
5. Dividend
5.1 Amount
No dividends for PHIA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
AMS:PHIA (12/22/2025, 3:48:12 PM)
22.685
-0.16 (-0.68%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners44.69%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap21.84B
Revenue(TTM)18.02B
Net Income(TTM)162.00M
Analysts74.81
Price Target27.59 (21.62%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP0.62%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.64%
Min EPS beat(2)22.24%
Max EPS beat(2)31.04%
EPS beat(4)2
Avg EPS beat(4)6.19%
Min EPS beat(4)-16.56%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-1.09%
EPS beat(12)5
Avg EPS beat(12)15.29%
EPS beat(16)5
Avg EPS beat(16)3.51%
Revenue beat(2)0
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-3.05%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)2
Avg Revenue beat(12)-1.61%
Revenue beat(16)2
Avg Revenue beat(16)-1.84%
PT rev (1m)0.7%
PT rev (3m)0.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.38%
EPS NY rev (1m)4.1%
EPS NY rev (3m)3.12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.41%
Revenue NY rev (1m)-0.35%
Revenue NY rev (3m)-0.62%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.33 | ||
| Fwd PE | 14.86 | ||
| P/S | 1.22 | ||
| P/FCF | 50.33 | ||
| P/OCF | 19.88 | ||
| P/B | 2.1 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.98 |
EPS(TTM)1.48
EY6.52%
EPS(NY)1.53
Fwd EY6.73%
FCF(TTM)0.45
FCFY1.99%
OCF(TTM)1.14
OCFY5.03%
SpS18.54
BVpS10.78
TBVpS-1.76
PEG (NY)3.53
PEG (5Y)N/A
Graham Number18.95
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROCE | 5.69% | ||
| ROIC | 4.27% | ||
| ROICexc | 4.72% | ||
| ROICexgc | 15.5% | ||
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% | ||
| FCFM | 2.43% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y10.6%
ROICexgc growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score8
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Debt/EBITDA | 3.01 | ||
| Cap/Depr | 51.35% | ||
| Cap/Sales | 3.72% | ||
| Interest Coverage | 4 | ||
| Cash Conversion | 46.06% | ||
| Profit Quality | 267.9% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z | 1.88 |
F-Score8
WACC6.47%
ROIC/WACC0.66
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
EPS Next Y4.35%
EPS Next 2Y4.98%
EPS Next 3Y7.73%
EPS Next 5Y13.05%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%
Revenue Next Year-2.27%
Revenue Next 2Y0.25%
Revenue Next 3Y1.58%
Revenue Next 5Y3.41%
EBIT growth 1Y476.21%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year50.79%
EBIT Next 3Y20.32%
EBIT Next 5YN/A
FCF growth 1Y3516.67%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y43.47%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%
KONINKLIJKE PHILIPS NV / PHIA.AS FAQ
Can you provide the ChartMill fundamental rating for KONINKLIJKE PHILIPS NV?
ChartMill assigns a fundamental rating of 3 / 10 to PHIA.AS.
Can you provide the valuation status for KONINKLIJKE PHILIPS NV?
ChartMill assigns a valuation rating of 4 / 10 to KONINKLIJKE PHILIPS NV (PHIA.AS). This can be considered as Fairly Valued.
Can you provide the profitability details for KONINKLIJKE PHILIPS NV?
KONINKLIJKE PHILIPS NV (PHIA.AS) has a profitability rating of 2 / 10.
How financially healthy is KONINKLIJKE PHILIPS NV?
The financial health rating of KONINKLIJKE PHILIPS NV (PHIA.AS) is 2 / 10.
What is the expected EPS growth for KONINKLIJKE PHILIPS NV (PHIA.AS) stock?
The Earnings per Share (EPS) of KONINKLIJKE PHILIPS NV (PHIA.AS) is expected to grow by 4.35% in the next year.